API reference

Varenicline tartrate

CAS number
375815-87-5
Molecular formula
C17H19N3O6
Molecular weight
361.3 g/mol
Varenicline tartrate — 2D structure
2D structure (PubChem)

About this molecule

Varenicline is a prescription medication used to treat smoking addiction. This medication is the first approved nicotinic receptor partial agonist. Specifically, varenicline is a partial agonist of the alpha4/beta2 subtype of the nicotinic acetylcholine receptor. In addition it acts on alpha3/beta4 and weakly on alpha3beta2 and alpha6-containing receptors. A full agonism was displayed on alpha7-receptors.

Source: Toxin and Toxin Target Database (T3DB), via PubChem.

Identifiers

IUPAC name
(2R,3R)-2,3-dihydroxybutanedioic acid;(1S,12R)-5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene
InChIKey
TWYFGYXQSYOKLK-CYUSMAIQSA-N
SMILES
C1[C@@H]2CNC[C@H]1C3=CC4=NC=CN=C4C=C23.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
PubChem CID
6918678

Also known as

Varenicline tartrate · TYRVAYA · CP-526,555-18 · 638-780-5 · Champix · Chantix · Varenicline tartrate? · Varenicline tartrate, >=98% (HPLC)

Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.

Tell us the grade, the quantity and the market.

Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.

Telephone+98 21 8888 3325 · office hours 09:00–17:00, Tehran
OfficeHaniya Parsan Darou, 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran 1968734974, Iran
Emailcontact@hanpars.com